Product Images Perindopril Erbumine

The text appears to be a chemical formula consisting of two molecules. The first molecule has a carbon atom double-bonded to an oxygen atom, followed by two carbon atoms, each attached to three hydrogen atoms and one methyl (CH3) group. The second molecule has a chain of carbon and nitrogen atoms, with variously attached methyl and ethyl groups. A meaningful description of the context and purpose of these molecules cannot be inferred from this text alone.*

This is a figure depicting the time to the occurrence of the primary endpoint, with the proportion of participants who had cardiovascular mortality, non-fatal M or cardiac arrest over time (measured in years). The figure compares the results for Placebo and Perindopril, and shows a Logrank p value of 0.0003 for the Placebo group. The number of patients "at risk" is shown for each group at each interval.*

This is a figure showing the beneficial effect of Perindopril treatment on the primary endpoint in predefined subgroups. The subgroups are divided into male and female categories and further categorized by age, previous myocardial infarction, hypertension, diabetes mellitus, lipid-lowering drugs, beta-blockers, and calcium-channel blockers. The size of the squares is proportional to the number of patients in each group, and a dashed line indicates the overall relative risk.*

Perindopril Erbumine Tablets 4mg Rx Only. Each tablet contains 4mg perindopril erbumine. It is recommended to keep out of reach of children. Dosage and administration details are provided in the accompanying literature. These tablets should be stored at a controlled room temperature between 20°C to 25°C (68°F to 77°F) and protected from moisture. The product is manufactured by Patheon Pharmaceuticals Inc., Cincinnati, USA, and distributed by Marlex Pharmaceuticals Inc., New Castle, USA. The package has 100 tablets and the NDC number is 10135-0599-01.*

This text describes a medication with the NDC code 10135-0600-01. Each tablet contains 8mg of perindopril erbumine. The instructions for dosage and administration can be found in accompanying literature. The medication should be stored at a controlled room temperature between 20°C to 25°C (68°F to 77°F) and protected from moisture. The medication is available in a bottle containing 100 tablets. This medication is manufactured by Patheon Pharmaceuticals, Inc in Cincinnati, Ohio, and distributed by Marlex Pharmaceuticals, Inc. It is made in the USA.*